Effect of Lower Limb Constraint Induced Movement Therapy Using a Torque-Assisted Exoskeletal Wearable Device

• Adults aged 19 years or older
• Patients with hemiparesis due to ischemic or hemorrhagic stroke
• Patients in the late subacute or chronic phase, at least 3 months after the onset of stroke
• Individuals who can independently walk with a Functional Ambulatory Category score of 3 or higher
• Patients who are able to use Torque-Assisted Exoskeletal Wearable Device Height: 140 cm to 190 cm Weight: 80 kg or less Shoe size: 230 mm to 290 mm
• Patients who were independent walkers and had no difficulties performing activities of daily living (mRS ≤ 1)

Exclusion Criteria:

• Patients with severe cognitive impairment (MMSE \<10) or significant communication difficulties such as speech disorders
• Patients with spasticity in one-sided lower limbs, rated 2 or higher on the Modified Ashworth Scale (MAS)
• Patients with severe musculoskeletal disorders of the lower limbs
• Patients with contractures that limit the range of motion in the lower limbs
• Patients with an apparent leg length discrepancy of 2 cm or more
• Patients with fractures, open trauma, or non-healing ulcers in the lower limbs
• Patients with serious internal diseases such as cardiovascular disease or pulmonary disease that make it difficult to use Exoskeletal Wearable Device for walking therapy
• Patients with a history of osteoporotic fractures
• Patients with other neurological disorders affecting walking (e.g., Parkinson's disease, multiple sclerosis, etc.)
• Any other cases where the investigator determines that participation in this study is inappropriate